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Background: Stroke is a debilitating condition with an increased risk in patients with atrial fibrillation (AF). While the use of anticoagulants is 
indicated for the prevention of stroke, it is unclear whether stroke risk differs between patients prescribed rhythm control versus rate control therapy. 
We aimed to compare risk of stroke between rhythm and rate control treatment strategies among patients with AF.
Methods: A population-based cohort study of Quebec patients ≥65 years with a diagnosis of AF during the period 1999 to 2007, using linked 
administrative data from hospital discharge and prescription drug claims databases.
Results: The cohort consisted of 16,325 patients who filled a prescription for rhythm control medication (with or without rate control medication) 
and 41,193 patients who filled a prescription for rate control medication (without rhythm control medication). A lower proportion of patients on 
rhythm control therapy than on rate control therapy had a CHADS2 score of ≥2 (58.1% vs. 67.0%, p<0.001). Treatment with any antithrombotic was 
comparable in the two strategies of treatment (77.8% vs. 76.8%). Stroke incidence rate was lower in patients treated with rhythm control compared 
to rate control therapy (1.43 vs. 2.07, per 100 person-years, p<0.001). However, once stratified according to CHADS2 score, the difference was 
statistically significant only in patients with high and moderate risk CHADS2 scores. In multivariable Cox regression analysis, patients on rhythm 
control therapy had a 21% reduction in stroke risk compared to patients on rate control therapy (adjusted HR 0.79, 95% CI: 0.73-0.86). The 
reduction in stroke rates was similar in a propensity score matched cohort.
Conclusions: Compared with rate control therapy, the use of rhythm control therapy was associated with a significantly lower stroke risk among 
patients with AF, particularly among those with moderate and high risk of stroke.
